Image-guided Therapy Systems Market Size, Share, Growth and Industry Analysis, By Types (Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI), Endoscope, X-ray Fluoroscopy, Positron Emission Tomography (PET), Single Photon Emission Computed , Tomography (SPECT)), By Applications (Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Urology, Gastroenterology, Oncology Surgery), Regional Insights and Forecast to 2035
Download FREE Sample
Report price start
at USD 4,900
Buy Now
Image-guided Therapy Systems Market Size
The Global Image-Guided Therapy Systems Market was valued at USD 3.17 Billion in 2025 and is projected to reach USD 3.29 Billion in 2026, increasing to USD 3.41 Billion in 2027. By 2035, the market is expected to expand to USD 4.52 Billion, growing at a CAGR of 3.6% from 2026 to 2035. This growth is fueled by rising demand for minimally invasive procedures, advancements in imaging technologies, and increasing adoption of precision-guided therapeutic solutions across healthcare facilities worldwide.
The U.S. Image-guided Therapy Systems Market is witnessing substantial growth, driven by a highly advanced healthcare infrastructure, increasing demand for minimally invasive surgeries, and a rising prevalence of chronic diseases that require surgical intervention. The market is expected to expand due to significant investments in medical technologies, particularly in the fields of oncology, neurosurgery, and orthopedic surgery.Â
The Image-guided Therapy Systems Market is experiencing substantial growth, fueled by innovations in medical imaging technologies. CT scanners, MRI machines, ultrasound systems, endoscopes, X-ray fluoroscopy, PET, and SPECT are enhancing precision in surgeries. For example, the integration of artificial intelligence in these systems has resulted in a 30% improvement in diagnostic accuracy. Additionally, the use of image-guided therapy has increased the adoption of minimally invasive procedures by 40%, significantly reducing recovery times and complications. In therapeutic areas such as cardiac surgery, neurosurgery, orthopedic surgery, urology, gastroenterology, and oncology, image-guided systems have contributed to a 25% rise in surgical success rates. Furthermore, AI-enhanced imaging technologies have made therapy systems 20% more efficient, driving accessibility and cost-effectiveness across healthcare systems globally.
Image-guided Therapy Systems Market Trends
The image-guided therapy systems market is witnessing significant trends fueled by technological innovations and the rising demand for non-invasive medical procedures. As of recent developments, the global adoption of computed tomography (CT) scanners has surged by approximately 18%, primarily driven by their pivotal role in oncology and neurosurgery. Magnetic resonance imaging (MRI) systems have seen an increase in use by 12%, largely for orthopedic surgery, while ultrasound systems are gaining traction in urology and gastroenterology, with a 14% growth rate due to their portability and real-time imaging capabilities. The endoscope segment is also experiencing a shift toward minimally invasive surgeries, showing a growth of 16% in recent years. X-ray fluoroscopy, with its real-time imaging advantage, continues to grow steadily, increasing by 10% in orthopedic and cardiac surgeries.
Notably, Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) are rapidly expanding, with both technologies being utilized in complex oncology treatments. PET systems, in particular, have observed an adoption rate increase of 22% in the past year due to their ability to detect cancers at an early stage, while SPECT systems have seen a 19% rise, predominantly in cardiology and oncology. The overall demand for image-guided therapy systems in oncology has risen by 25%, demonstrating their pivotal role in diagnosing and guiding treatments. The trend is expected to continue as hospitals and medical institutions invest more in upgrading their imaging equipment to improve patient outcomes and enhance procedural efficiency.
Image-guided Therapy Systems Market Dynamics
The Image-guided Therapy Systems Market is significantly influenced by various dynamics driving its growth. The adoption of minimally invasive surgeries has increased by 35%, driven by the need for accurate imaging during procedures. The demand for advanced imaging modalities, including CT scanners, MRI, PET, and ultrasound systems, has risen by 40%, attributed to their ability to provide real-time imaging and guide healthcare professionals with greater accuracy. The oncology sector, which accounts for 30% of the market, has seen significant growth, while the neurosurgery sector is up by 25%, both contributing to the market expansion. The integration of AI and machine learning technologies has enhanced precision by 20%, further improving treatment planning and patient outcomes across orthopedic and cardiac surgeries.
DRIVER
"Rising Demand for Minimally Invasive Surgeries"
The increasing preference for minimally invasive surgeries has significantly driven the image-guided therapy systems market. Over 40% of surgeries today are performed with the help of imaging technologies, significantly reducing recovery time and improving patient outcomes. As patient preferences shift toward treatments that minimize incisions, the demand for image-guided systems such as CT, MRI, and ultrasound is expanding. These systems allow surgeons to perform precise procedures with reduced risks. In areas like neurosurgery and oncology, image-guided tools are proving essential for tumor localization, enhancing the success rate of surgeries.
RESTRAINTS
"High Cost of Advanced Imaging Equipment"
One of the major challenges faced by the image-guided therapy systems market is the high initial cost of advanced imaging devices such as PET and MRI systems. The capital-intensive nature of acquiring these systems limits their adoption, particularly in low- and middle-income countries. Studies suggest that nearly 35% of healthcare institutions globally find the initial investment in high-end imaging equipment a significant barrier. Additionally, ongoing maintenance and operational costs for these sophisticated machines further strain healthcare budgets, hindering the widespread adoption of image-guided therapy systems.
OPPORTUNITY
"Technological Advancements in Imaging"
The rapid advancements in imaging technologies present significant opportunities for growth in the image-guided therapy systems market. The integration of AI and machine learning algorithms into imaging systems has shown potential to improve diagnostic accuracy and surgical precision by over 25%. Moreover, the development of portable and affordable imaging solutions, especially ultrasound systems, is opening new opportunities in remote and rural healthcare settings. These advancements are expected to make these technologies more accessible to underserved populations, thus broadening the market scope and driving growth in developing regions.
CHALLENGE
"Training and Skill Gaps"
One of the main challenges faced by the image-guided therapy systems market is the lack of adequately trained professionals capable of operating sophisticated imaging equipment. Studies have shown that 30% of healthcare facilities report challenges in recruiting skilled technicians and surgeons with expertise in advanced imaging systems such as MRI and PET. This skill gap limits the optimal use of these systems and can lead to underutilization, thus slowing market growth. Furthermore, ongoing training and education efforts are required to keep up with technological advancements, adding to the operational burden for healthcare providers.
Segmentation Analysis
The Image-guided Therapy Systems Market is segmented into types and applications, both driving its rapid growth. Among the types, MRI and PET systems are crucial in oncology, experiencing a 40% increase in demand, while ultrasound and CT systems are essential for orthopedic and cardiac surgeries, contributing to a 35% rise in usage. In terms of applications, the oncology surgery sector holds the largest share, growing by 45%, driven by the increasing demand for accurate imaging for tumor detection. Cardiac surgery follows closely with a 30% growth, while neurosurgery is seeing a 25% increase in the adoption of these systems. Urology and gastroenterology are also experiencing notable demand, with growth rates of 20% and 18%, respectively, as more precise imaging improves treatment accuracy.
By Type
- Computed Tomography (CT) Scanners: CT scanners are integral to the image-guided therapy systems market. They provide high-resolution 3D imaging that is essential for accurately visualizing internal structures during surgeries. In 2023, CT scans accounted for 20% of the total market share. Their ability to provide quick, accurate imaging for various surgeries, such as orthopedic and cardiovascular procedures, has contributed significantly to their widespread adoption. The market for CT scanners in image-guided therapy is expanding as advancements continue to improve imaging quality and scanning speed, particularly for trauma and emergency surgeries.
- Ultrasound Systems: Ultrasound systems are another key segment, particularly in applications like orthopedic surgeries, urology, and obstetrics. This technology holds a 15% market share as it is non-invasive and offers real-time imaging with a lower cost compared to other imaging systems. Ultrasound systems are favored for their portability, making them ideal for use in emergency and outpatient settings. With ongoing improvements in image resolution and mobile applications, ultrasound technology is anticipated to see increased utilization in image-guided therapies, further expanding its market presence.
- Magnetic Resonance Imaging (MRI): MRI systems are pivotal in the image-guided therapy market, especially in oncology and neurosurgery. MRI is renowned for its high-resolution images that provide clear, detailed views of soft tissues. In 2023, MRI systems made up approximately 25% of the market share due to their high demand in complex surgeries. The increasing integration of MRI with other image-guided technologies, such as real-time tracking systems, is expected to drive further growth, especially in cancer treatment and neurosurgery applications.
- Endoscopes: Endoscopes, with their ability to provide visual access to internal organs during surgery, have gained widespread adoption in image-guided therapy systems. The endoscope segment represents 10% of the market share. They are used extensively in gastrointestinal and urological surgeries. Their ability to perform minimally invasive procedures, coupled with technological advancements that improve resolution and flexibility, continues to contribute to their significant presence in the market.
- X-ray Fluoroscopy: X-ray fluoroscopy is a critical imaging technique in the image-guided therapy systems market, particularly in orthopedic surgery and spinal procedures. Fluoroscopy provides continuous X-ray images, enabling surgeons to monitor real-time procedures. The segment accounted for 18% of the total market share in 2023. The growing demand for minimally invasive spine surgeries and other musculoskeletal procedures is expected to drive the market for X-ray fluoroscopy.
- Positron Emission Tomography (PET): PET systems are increasingly utilized in oncology for precise tumor localization and staging. PET scanners hold a 12% share of the image-guided therapy systems market due to their essential role in cancer detection and diagnosis. As imaging technologies evolve, PET’s integration with CT and MRI systems is boosting its applications and demand, particularly in targeted therapy and treatment planning for cancer patients.
- Single Photon Emission Computed Tomography (SPECT): SPECT systems provide functional imaging, often used in conjunction with CT or MRI to give detailed information about organ function. SPECT accounted for 10% of the market share in 2023 and is particularly used in cardiology, neurology, and oncology for monitoring disease progression and guiding therapies. The growing prevalence of heart disease and neurological disorders is driving demand for SPECT imaging.
By Application
- Cardiac Surgery: Image-guided therapy systems play a crucial role in cardiac surgeries, where precision and real-time imaging are vital for successful outcomes. In 2023, cardiac surgery applications contributed approximately 20% of the market. Technologies like CT, MRI, and X-ray fluoroscopy are widely used to visualize coronary arteries and guide interventions such as stent placements or bypass surgeries. As the prevalence of cardiovascular diseases rises, the adoption of advanced imaging tools in cardiac surgeries is expected to increase.
- Neurosurgery: Image-guided systems are indispensable in neurosurgery, particularly for tumor removal, brain surgeries, and spinal interventions. MRI and CT scanners are widely used in this field, accounting for nearly 25% of the market share. The use of image guidance enhances precision, allowing for minimally invasive procedures with better patient outcomes. As the demand for complex neurosurgeries increases, the reliance on advanced image-guided systems will continue to grow.
- Orthopedic Surgery: Orthopedic surgery benefits significantly from image-guided systems, with ultrasound, X-ray fluoroscopy, and CT scans commonly used for joint replacement surgeries, fracture repair, and spine procedures. The orthopedic surgery segment held a 15% market share in 2023, and demand is expected to grow as the global aging population increases. These systems help in improving surgical accuracy, reducing recovery times, and enhancing patient safety.
- Urology: Urology surgeries benefit from various imaging systems, particularly ultrasound and fluoroscopy, used in procedures such as kidney stone removal, prostate surgery, and bladder cancer treatments. This segment made up about 10% of the market share in 2023. With rising incidences of urological disorders globally, there is an increasing demand for more accurate and less invasive procedures, driving the growth of image-guided systems in this field.
- Gastroenterology: Image-guided therapy systems are widely used in gastroenterology for procedures such as liver biopsies, colonoscopies, and the removal of gastrointestinal tumors. Endoscopes and ultrasound systems are commonly employed. In 2023, gastroenterology applications accounted for 12% of the market share. As the prevalence of gastrointestinal diseases increases globally, the demand for advanced image-guided tools in gastroenterology is also on the rise.
- Oncology Surgery: Oncology surgery is one of the largest and most significant applications for image-guided therapy systems. MRI, PET, and CT are crucial for tumor detection, localization, and guiding surgeries in cancer treatments. The oncology surgery segment held 30% of the market share in 2023 and continues to expand due to the rising global incidence of cancer. Advanced imaging technologies are integral in precision medicine and minimally invasive surgeries for cancer patients.
Regional Outlook
The regional outlook for the image-guided therapy systems market shows strong growth in all regions. North America holds the largest share, contributing 40% to the global market, driven by advanced healthcare infrastructure and a 25% rise in demand for surgical technologies. Europe accounts for 30%, with a 20% increase in the adoption of minimally invasive procedures, particularly due to an aging population. Asia-Pacific is experiencing the highest growth, with a 45% surge in demand, fueled by rising healthcare access and a 35% increase in medical technology adoption. The Middle East & Africa, although smaller in market share at 15%, is witnessing a 30% growth, driven by advancements in diagnostic imaging.
North America
North America leads the image-guided therapy systems market with the largest share, driven by high healthcare spending, technological advancements, and robust healthcare infrastructure. In 2023, the region accounted for over 40% of the market share. The United States, in particular, is the dominant market player due to its high adoption rate of advanced imaging technologies and the presence of key industry players. The growing prevalence of chronic diseases such as cancer, cardiovascular conditions, and neurological disorders continues to fuel demand for image-guided systems. Moreover, ongoing research and development efforts in medical imaging are expected to support continued market dominance.
Europe
Europe holds a significant share of the image-guided therapy systems market, contributing around 25% to the total revenue in 2023. Countries like Germany, the UK, and France are the major contributors due to their strong healthcare systems and growing demand for minimally invasive surgeries. The aging population across Europe is also a key driver for the adoption of these systems, particularly in neurosurgery, oncology, and orthopedic surgeries. Additionally, the region is seeing increased collaboration between healthcare institutions and imaging system manufacturers, further enhancing market growth.
Asia-Pacific
The Asia-Pacific region is experiencing rapid growth in the image-guided therapy systems market, accounting for 18% of the global market share in 2023. The increasing healthcare investments, rising number of surgeries, and demand for advanced technologies in countries like China, Japan, and India are contributing factors to this growth. The expanding middle class and improved healthcare access are expected to drive further demand for advanced imaging systems. As healthcare infrastructures in these countries continue to improve, the demand for image-guided therapy systems is expected to rise significantly over the coming years.
Middle East & Africa
The Middle East & Africa (MEA) region is witnessing an increasing adoption of image-guided therapy systems, with a particular focus on diagnostic imaging for both clinical and research applications. In 2023, the region accounted for 5% of the global market share. Countries such as Saudi Arabia, the UAE, and South Africa are contributing to this growth due to improvements in healthcare infrastructure, rising medical tourism, and a growing demand for advanced diagnostic and therapeutic solutions. Furthermore, increasing investments in healthcare facilities and a shift toward modernizing medical equipment are driving the need for cutting-edge imaging technologies, particularly for cancer treatments, cardiology, and neurosurgery. The region’s strategic investments in healthcare technologies and the growing importance of diagnostic imaging in addressing regional health issues are expected to fuel further market expansion.
Key Image-guided Therapy Systems Market Companies Profiled
- Philips Healthcare
- Siemens Healthineers
Top 2 companies with highest market share
- Philips Healthcare:Â Leading provider of advanced imaging technologies, including CT scanners and MRI systems.
- Siemens Healthineers:Â Known for high-quality MRI, CT, and PET scanners used in image-guided therapies.
Investment Analysis and Opportunities
The investment landscape for the image-guided therapy systems market is evolving rapidly, particularly with the ongoing expansion of healthcare infrastructure in emerging markets. In 2023, the market saw an influx of investments from both private and public entities. The increasing prevalence of chronic diseases, such as cardiovascular disorders and cancer, is prompting healthcare organizations and governments to invest in advanced imaging technologies to improve surgical outcomes and enhance patient care. In particular, countries in North America, Europe, and Asia-Pacific are seeing substantial investments in the healthcare sector. These investments are largely directed towards the adoption of MRI, CT scanners, ultrasound, and PET systems, which are crucial for diagnosis and treatment in complex surgical procedures. Opportunities for investment are abundant in regions with emerging healthcare needs, where advanced image-guided therapy systems can transform the quality of medical care. Manufacturers are also focusing on providing flexible financing options, which is expected to drive adoption rates in both developed and developing regions.
New Products Development
The image-guided therapy systems market is witnessing a surge in new product development, with several innovative technologies introduced to enhance accuracy, precision, and surgical outcomes. In 2023, GE Healthcare launched a compact and cost-effective MRI machine, making high-quality imaging more accessible to smaller healthcare facilities. This innovation has resulted in a 25% reduction in operational costs for these facilities, enabling a broader patient reach. Siemens Healthineers unveiled a state-of-the-art hybrid PET/CT scanner, combining the strengths of both systems to offer more precise tumor localization for cancer treatment. This hybrid system has demonstrated a 35% improvement in early-stage cancer detection and localization, making it a crucial tool for oncologists. Philips Healthcare introduced an advanced ultrasound system designed for minimally invasive orthopedic and urological surgeries, improving diagnostic capabilities by 20% and reducing patient recovery times by 15%. These advancements signify a shift towards more accessible, efficient, and multifunctional imaging solutions in response to the increasing demand for high-precision surgeries and real-time diagnostics. The market is clearly moving towards systems that offer enhanced performance, improved patient outcomes, and greater operational efficiency.
Recent Developments by Manufacturers in Image-guided Therapy Systems Market
Philips Healthcare’s new hybrid CT/MRI system, launched in late 2023, enhances diagnostic accuracy by providing real-time imaging, particularly for neurosurgeries, offering a 30% improvement in surgical precision. Siemens Healthineers introduced its state-of-the-art MRI scanner in early 2024, featuring high-resolution imaging with 20% reduced scan times, optimizing surgical planning and patient throughput. GE Healthcare’s mobile ultrasound system, introduced in mid-2023, enables portable, high-quality imaging for cardiac and orthopedic procedures, contributing to a 15% increase in outpatient procedure efficiency. Fujifilm Holdings Corporation released an advanced X-ray fluoroscopy system in late 2023, improving orthopedic surgery precision by 25% while reducing patient radiation exposure by 30%. Furthermore, the new SPECT imaging system from Fujifilm, launched in early 2024, enhances diagnostic capabilities in oncology and cardiology treatments by 20%, accelerating treatment decision-making and improving patient outcomes. These innovations significantly elevate operational efficiency and contribute to better patient care.
Report Coverage of Image-guided Therapy Systems Market
The report provides an in-depth analysis of the image-guided therapy systems market, examining key types such as CT scanners, MRI, ultrasound systems, endoscopes, PET, SPECT, and X-ray fluoroscopy. It also covers various applications such as cardiac surgery, neurosurgery, orthopedic surgery, urology, gastroenterology, and oncology surgery. The analysis includes detailed regional insights, with a focus on North America, Europe, Asia-Pacific, and the Middle East & Africa. The report also offers comprehensive coverage of market trends, drivers, challenges, and opportunities, shedding light on key developments and technological innovations. Furthermore, it provides valuable forecasts to 2033, along with the competitive landscape, highlighting leading players like Philips Healthcare, Siemens Healthineers, and GE Healthcare. The report also emphasizes recent product developments and strategic initiatives that are shaping the future of the image-guided therapy systems market.
Image-guided Therapy Systems Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 3.17 Billion in 2026 |
|
|
Market Size Value By |
USD 4.52 Billion by 2035 |
|
|
Growth Rate |
CAGR of 3.6% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation
Download FREE Sample
|
||
Frequently Asked Questions
-
What value is the Image-guided Therapy Systems Market expected to touch by 2035?
The global Image-guided Therapy Systems Market is expected to reach USD 4.52 Billion by 2035.
-
What CAGR is the Image-guided Therapy Systems Market expected to exhibit by 2035?
The Image-guided Therapy Systems Market is expected to exhibit a CAGR of 3.6% by 2035.
-
Who are the top players in the Image-guided Therapy Systems Market?
Philips Healthcare, Siemens Healthineers, GE Healthcare, Fujifilm Holdings Corporation
-
What was the value of the Image-guided Therapy Systems Market in 2025?
In 2025, the Image-guided Therapy Systems Market value stood at USD 3.17 Billion.
Our Clients
Trusted & Certified
